Pharmaceutical Sales 2010

The following is a list of the top 200 Drugs by units sold in 2010, listed by U.S. units sold and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2010 by Units Sold

View data for: 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Rxs (000) % Change 2009
1 Lipitor Pfizer Inc 37,523 -11.3%
2 Nexium AstraZeneca Pharmaceuticals, LP 25,872 -1.7%
3 Plavix Bristol-Myers Squibb Company 25,000 -2.1%
4 Singulair Merck & Co., Inc. 24,666 -0.5%
5 Lexapro Forest Pharmaceuticals, Inc 23,000 -4.1%
6 (2) Crestor AstraZeneca Pharmaceuticals, LP 20,945 14.4%
7 Synthroid Abbott Laboratories 20,272 -4.5%
8 (2) ProAir HFA Teva Pharmaceuticals 18,616 -15.7%
9 Advair Diskus GlaxoSmithKline 16,580 -4.7%
10 (1) Cymbalta Eli Lilly and Company 14,591 -1.3%
11 (1) Diovan Novartis Corporation 14,360 -3.2%
12 (18) Ventolin HFA GlaxoSmithKline 13,523 68.4%
13 (2) Diovan HCT Novartis Corporation 11,480 -6.7%
14 (2) Actos Takeda Pharmaceuticals U.S.A., Inc 11,193 -3.5%
15 (3) Seroquel AstraZeneca Pharmaceuticals, LP 10,260 -6.9%
16 (3) Levaquin Janssen Pharmaceuticals, Inc 9,322 -12.4%
17 (8) Lantus Sanofi (formerly Sanofi Aventis) 8,960 -5.9%
18 (8) Nasonex Merck & Co., Inc. 8,834 -7.9%
19 (4) Viagra Pfizer Inc 8,829 -7.4%
20 (7) Lyrica Pfizer Inc 8,714 -5.1%
21 (3) Celebrex Pfizer Inc 8,643 -9.8%
22 (10) Concerta Johnson & Johnson 7,949 2.7%
23 (12) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 7,738 5.3%
24 (4) Premarin tabs Wyeth 7,691 -14.7%
25 (13) Effexor XR Pfizer Inc 7,603 -44.1%
26 (6) Tricor Abbott Laboratories 7,588 -23.1%
27 (2) Zetia Merck & Co., Inc. 7,398 -14.8%
28 (6) Vytorin Merck & Co., Inc. 7,165 -25.3%
29 (12) OxyContin Purdue Pharma LP 6,869 7.5%
30 (9) Abilify Bristol-Myers Squibb Company 6,799 6.0%
31 (32) Loestrin 24 Fe Teva Pharmaceuticals 6,693 65.5%
32 (21) Vyvanse Shire US Inc 6,604 31.3%
33 (7) Cialis Eli Lilly and Company 6,584 5.2%
34 (16) Suboxone Reckitt Benckiser Pharmaceuticals Inc. 6,476 24.2%
35 (3) Aricept Eisai Corporation 6,252 -4.0%
36 Benicar Daiichi Sankyo 6,098 -10.8%
37 (8) Januvia Merck & Co., Inc. 5,919 5.5%
38 (9) Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 5,714 7.5%
39 (2) Ambien CR Sanofi (formerly Sanofi Aventis) 5,687 -16.7%
40 (8) Niaspan Abbott Laboratories 5,618 5.6%
41 (3) Xalatan Pfizer Inc 5,516 -3.3%
42 Levoxyl King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 5,452 -16.9%
43 Benicar HCT Daiichi Sankyo 5,215 -12.7%
44 (13) Flovent HFA GlaxoSmithKline 5,047 9.5%
45 (11) NuvaRing Merck & Co., Inc. 4,756 1.7%
46 () Lovaza GlaxoSmithKline 4,583 12.0%
47 (26) Yaz Bayer Healthcare Pharmaceuticals 4,567 -54.5%
48 (16) NovoLog Novo Nordisk, Inc. 4,443 10.2%
49 (10) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 4,270 -5.1%
50 (12) Namenda Forest Pharmaceuticals, Inc 4,193 4.2%
51 (1) Detrol LA Pfizer Inc 4,160 -18.8%
52 (13) Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 4,157 8.7%
53 (27) Lantus SoloSTAR Sanofi (formerly Sanofi Aventis) 4,035 40.5%
54 (8) Proventil HFA Merck & Co., Inc. 3,952 -30.3%
55 Aciphex Eisai Corporation 3,897 -18.6%
56 (2) Avapro Bristol-Myers Squibb Company 3,811 -17.2%
57 (41) Bystolic Forest Pharmaceuticals, Inc 3,666 62.6%
58 (7) Adderall XR Shire US Inc 3,625 -29.6%
59 (30) Symbicort AstraZeneca Pharmaceuticals, LP 3,618 42.1%
60 (8) Zyprexa Eli Lilly and Company 3,616 -0.9%
61 (56) Trilipix Abbott Laboratories 3,608 84.2%
62 (2) Boniva Genentech, Inc (member of Roche group) 3,524 -14.7%
63 (9) Avodart GlaxoSmithKline 3,466 0.3%
64 (22) Glipizide XL Greenstone LLC 3,423 24.2%
65 (36) Pristiq Wyeth 3,412 49.9%
66 (5) Lidoderm Endo Pharmaceuticals 3,402 -2.6%
67 (2) Humalog Eli Lilly and Company 3,343 -6.2%
68 (6) Vigamox Alcon Laboratories, Inc. 3,327 -1.9%
69 (2) Evista Eli Lilly and Company 3,296 -11.4%
70 (53) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 3,132 -73.1%
71 (5) Chantix Pfizer Inc 2,980 -20.9%
72 (2) Avalide Bristol-Myers Squibb Company 2,879 -17.6%
73 (5) Protonix Wyeth 2,848 -9.2%
74 (43) Cozaar Merck & Co., Inc. 2,837 -64.0%
75 (9) Vivelle-DOT Novartis Corporation 2,832 1.6%
76 (12) Vesicare Astellas Pharma US 2,814 6.2%
77 (17) Prempro Pfizer Inc 2,702 11.7%
78 (1) Avelox Bayer Healthcare Pharmaceuticals 2,693 -15.1%
79 () Dexilant/Kapidex 2,675 233.3%
80 (15) Focalin XR Novartis Corporation 2,667 11.8%
81 Strattera Eli Lilly and Company 2,606 -7.8%
82 (1) Xopenex HFA Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 2,584 -8.3%
83 (22) Actonel Procter & Gamble 2,558 -37.6%
84 (36) Travatan Z Alcon Laboratories, Inc. 2,543 33.6%
85 (34) Levemir Novo Nordisk, Inc. 2,535 29.6%
86 (5) Lumigan Allergan, Inc 2,518 2.8%
87 (18) Apri Teva Pharmaceuticals 2,394 10.5%
88 (6) Levitra Bayer Healthcare Pharmaceuticals 2,359 -17.5%
89 (8) Geodon oral Pfizer Inc 2,332 0.3%
90 (6) Micardis Boehringer Ingelheim Pharmaceuticals, Inc 2,324 2.4%
91 (16) Exforge Novartis Corporation 2,267 6.6%
92 (5) Coumadin tabs Bristol-Myers Squibb Company 2,248 -18.6%
93 (22) Janumet Merck & Co., Inc. 2,245 14.9%
94 (18) Ciprodex otic Alcon Laboratories, Inc. 2,204 4.2%
95 (62) Valtrex GlaxoSmithKline 2,180 -71.7%
96 (15) Restasis Allergan, Inc 2,156 3.5%
97 (74) Seroquel XR AstraZeneca Pharmaceuticals, LP 2,101 94.4%
98 (6) Micardis HCT Abbott Laboratories 2,088 -1.3%
99 (38) Actonel 150 Procter & Gamble 2,045 12.5%
100 (7) Lotrel Novartis Corporation 2,041 -17.4%
101 (25) Tussionex Sanofi (formerly Sanofi Aventis) 2,024 -39.0%
102 (16) Prometrium Solvay Pharmaceuticals, Inc. 1,989 -1.4%
103 (21) AndroGel Abbott Laboratories 1,969 6.7%
104 (4) Kariva Teva Pharmaceuticals 1,967 -15.8%
105 (4) Patanol Alcon Laboratories, Inc. 1,960 -7.4%
106 (44) Voltaren gel Endo Pharmaceuticals 1,931 34.3%
107 (58) Hyzaar Merck & Co., Inc. 1,899 -64.7%
108 (35) Thyroid, Armour Forest Pharmaceuticals, Inc 1,893 -43.6%
109 (17) Nasacort AQ Sanofi (formerly Sanofi Aventis) 1,807 -25.6%
110 (12) Coreg CR GlaxoSmithKline 1,782 -7.2%
111 (46) Qvar Janssen Pharmaceuticals, Inc 1,781 30.4%
112 (35) Pataday Alcon Laboratories, Inc. 1,755 16.4%
113 (11) Xyzal Sanofi (formerly Sanofi Aventis) 1,747 -24.4%
114 (11) Humulin N Eli Lilly and Company 1,715 -4.4%
115 (16) Vagifem Novo Nordisk, Inc. 1,650 -3.1%
116 (62) Toprol XL AstraZeneca Pharmaceuticals, LP 1,650 -67.6%
117 (7) Byetta Amylin Pharmaceuticals, Inc. 1,638 -22.1%
118 (21) NovoLog Mix 70/30 Novo Nordisk, Inc. 1,633 6.9%
119 (11) Veramyst GlaxoSmithKline 1,584 -9.9%
120 (39) Azor Daiichi Sankyo 1,562 21.5%
121 (13) Caduet Pfizer Inc 1,561 -26.2%
122 (33) Welchol Daiichi Sankyo 1,560 13.2%
123 (10) Actoplus Met Takeda Pharmaceuticals U.S.A., Inc 1,531 -3.4%
124 (10) Provigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 1,517 -29.1%
125 (11) Epipen 1,512 -1.1%
126 (6) Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc 1,497 -6.9%
127 (11) Dilantin Pfizer Inc 1,475 -4.9%
128 (24) Enablex Warner Chilcott 1,466 3.0%
129 (13) Alphagan P Allergan, Inc 1,461 -27.0%
130 (11) Premarin vaginal Pfizer Inc 1,452 -4.6%
131 (4) Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 1,444 -20.6%
132 (14) Uroxatral 1,419 -4.4%
133 (10) Asmanex Merck & Co., Inc. 1,412 -4.0%
134 (10) Prevacid SoluTab Takeda Pharmaceuticals U.S.A., Inc 1,393 -4.9%
135 (29) Moviprep Salix Pharmaceuticals, Ltd 1,363 21.7%
136 (33) Avandia GlaxoSmithKline 1,345 -40.0%
137 (24) Tekturna Novartis Corporation 1,321 5.3%
138 (11) Propecia Merck & Co., Inc. 1,319 -9.4%
139 (6) Ortho Evra Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1,312 -13.9%
140 (35) Solodyn Medicis Pharmaceutical Corporation 1,311 19.1%
141 (4) Humulin 70/30 Eli Lilly and Company 1,298 -14.7%
142 (36) Lanoxin GlaxoSmithKline 1,265 -41.2%
143 (8) Asacol Procter & Gamble 1,258 -19.1%
144 (130) Prevacid Takeda Pharmaceuticals U.S.A., Inc 1,248 -90.5%
145 (17) Atacand AstraZeneca Pharmaceuticals, LP 1,238 -29.2%
146 (27) Nitrostat Pfizer Inc 1,220 17.8%
147 (40) Combigan Allergan, Inc 1,169 27.8%
148 () Halflytely bwl prep 1,128 -28.9%
149 (14) Relpax Pfizer Inc 1,113 -8.2%
150 (20) Novolin 70/30 Novo Nordisk, Inc. 1,106 -1.0%
151 (18) Femara Novartis Corporation 1,098 -0.6%
152 (118) Tamiflu Genentech, Inc (member of Roche group) 1,094 -85.3%
153 (14) Zovirax topical GlaxoSmithKline 1,075 -5.1%
154 (4) Lovenox Sanofi (formerly Sanofi Aventis) 1,057 -22.2%
155 (13) Zymar Allergan, Inc 1,055 -31.5%
156 (10) Maxalt Merck & Co., Inc. 1,028 -7.5%
157 (25) Estrace vaginal Bristol-Myers Squibb Company 1,024 7.4%
158 () Exelon Patch Novartis Corporation 1,008 24.9%
159 () Intuniv Shire US Inc 983 NA
160 Allegra-D 24 Hour Sanofi (formerly Sanofi Aventis) 975 -25.3%
161 () Astepro 0.15 955 NA
162 (12) Maxalt MLT Merck & Co., Inc. 949 -8.3%
163 (34) Arimidex AstraZeneca Pharmaceuticals, LP 946 -45.5%
164 (15) Amitiza Takeda Pharmaceuticals U.S.A., Inc 941 -1.8%
165 () Doryx Pfizer Inc 939 13.4%
166 (15) Differin Galderma Laboratories 913 -37.0%
167 (27) Clarinex Merck & Co., Inc. 906 -43.2%
168 (24) Lotemax Bausch & Lomb Inc. 905 1.3%
169 (46) Astelin Meda Pharmaceuticals 896 -52.5%
170 (27) Transderm-Scop Baxter International Inc 883 4.6%
171 (10) Humulin R Eli Lilly and Company 878 -6.9%
172 (19) Levothroid Forest Pharmaceuticals, Inc 869 -40.2%
173 () Advair HFA GlaxoSmithKline 868 22.0%
174 (10) Truvada Gilead Sciences, Inc. 866 -7.5%
175 () Nuvigil Cephalon, Inc. (a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd) 852 194.8%
176 () SF 5000 Plus Cypress Pharmaceuticals 838 12.3%
177 (9) Yasmin 28 Bayer Healthcare Pharmaceuticals 837 -28.7%
178 (1) Bactroban GlaxoSmithKline 824 -17.7%
179 () Ranexa Gilead Sciences, Inc. 816 32.8%
180 (15) Metadate CD UCB Inc. 810 -6.8%
181 (25) Lamictal GlaxoSmithKline 801 -42.3%
182 (16) Atrovent HFA Boehringer Ingelheim Pharmaceuticals, Inc 800 -5.7%
183 () Simcor Abbott Laboratories 800 14.9%
184 () Opana ER Endo Pharmaceuticals 794 39.4%
185 (23) Rhinocort Aqua AstraZeneca Pharmaceuticals, LP 774 -36.8%
186 (4) Humalog Mix 75/25 Pen Eli Lilly and Company 769 -14.7%
187 () Carafate Actavis 764 7.5%
188 (8) Norvir Abbott Laboratories 762 -10.9%
189 () Aspir-Low Major Pharmaceuticals 760 2.2%
190 (36) BenzaClin Sanofi (formerly Sanofi Aventis) 759 -45.3%
191 (101) Skelaxin Elan Corporation 759 -70.2%
192 (6) Duac Care System GlaxoSmithKline 755 -15.4%
193 (17) Wellbutrin XL Valeant Pharmaceuticals International 753 -26.7%
194 (1) Arthrotec Pfizer Inc 752 -15.7%
195 () Epiduo Galderma Laboratories 742 43.5%
196 () Pulmicort Flexhaler AstraZeneca Pharmaceuticals, LP 735 -6.7%
197 () Omnaris Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 734 79.3%
198 () Ortho Tri-Cyclen Janssen Pharmaceuticals, Inc 732 16.1%
199 (5) Prandin Novo Nordisk, Inc. 726 -15.0%
200 () Nevanac Alcon Laboratories, Inc. 725 16.1%

Source: Verispan, VONA

View data for: 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web5)